See also this year's filing and all EDGAR filings for this company.
PDF Report 0000707511_2018_REGENERX_BIOPHARMACEUTICALS_INC.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000707511')"} |
Graph
Absolute values for 0000707511, REGENERX BIOPHARMACEUTICALS INC
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 217,150 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 4,171 |
3 | remainder_Assets | 5,752 |
4 | LiabilitiesCurrent | 2,153,089 |
5 | LiabilitiesNoncurrent | 0 |
6 | remainder_Liabilities | 2,190,276 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 1,357,371 |
9 | ResearchAndDevelopmentExpense | 143,911 |
10 | remainder_Expenses | 98,605 |
11 | remainder_Revenues | 56,652 |
12 | remainder_NetIncome | 1,829,722 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 227,073 |
1 | Liabilities | 4,343,365 |
2 | Expenses | 1,599,887 |
3 | Revenues | 56,652 |
4 | StockholdersEquity | -4,116,292 |
5 | NetIncome | 286,487 |
6 | ComprehensiveNetIncome | 286,487 |
7 | BaseVar | 4,028,350 |
8 | EconomicCapitalRatio | -2.97 |